Cargando…
Clinical importance of serum secreted clusterin in predicting invasive breast cancer and treatment responses
Enhanced serum secreted clusterin (sCLU) protein was associated with progression, poor prognosis and chemotherapy sensitivity evaluation in malignant patients. However, the clinical significance of serum sCLU protein levels in patients with invasive breast cancer (IBC) is unknown. In this study, the...
Autores principales: | Chen, Qing-Feng, Chang, Lei, Su, Qun, Zhao, Ying, Kong, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806267/ https://www.ncbi.nlm.nih.gov/pubmed/33356806 http://dx.doi.org/10.1080/21655979.2020.1868732 |
Ejemplares similares
-
Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting Clusterin improves response to paclitaxel
por: Hassan, Mohamed K, et al.
Publicado: (2011) -
Clusterin serum levels are elevated in patients with early rheumatoid arthritis and predict disease activity and treatment response
por: Kropáčková, Tereza, et al.
Publicado: (2021) -
Reduced secreted clusterin as a mechanism for Alzheimer-associated CLU mutations
por: Bettens, Karolien, et al.
Publicado: (2015) -
The role of Clusterin in cancer metastasis
por: Peng, Mei, et al.
Publicado: (2019) -
Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria
por: Kim, Ji-Hye, et al.
Publicado: (2016)